260 related articles for article (PubMed ID: 17540773)
1. The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells.
Lee NY; Blobe GC
J Biol Chem; 2007 Jul; 282(29):21507-17. PubMed ID: 17540773
[TBL] [Abstract][Full Text] [Related]
2. Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC.
Lee NY; Ray B; How T; Blobe GC
J Biol Chem; 2008 Nov; 283(47):32527-33. PubMed ID: 18775991
[TBL] [Abstract][Full Text] [Related]
3. The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2.
You HJ; How T; Blobe GC
Carcinogenesis; 2009 Aug; 30(8):1281-7. PubMed ID: 19325136
[TBL] [Abstract][Full Text] [Related]
4. Endoglin inhibits ERK-induced c-Myc and cyclin D1 expression to impede endothelial cell proliferation.
Pan CC; Bloodworth JC; Mythreye K; Lee NY
Biochem Biophys Res Commun; 2012 Aug; 424(3):620-3. PubMed ID: 22789855
[TBL] [Abstract][Full Text] [Related]
5. ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration.
Ray BN; Lee NY; How T; Blobe GC
Carcinogenesis; 2010 Mar; 31(3):435-41. PubMed ID: 20042635
[TBL] [Abstract][Full Text] [Related]
6. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.
Scherner O; Meurer SK; Tihaa L; Gressner AM; Weiskirchen R
J Biol Chem; 2007 May; 282(19):13934-43. PubMed ID: 17376778
[TBL] [Abstract][Full Text] [Related]
7. Endoglin mediates fibronectin/α5β1 integrin and TGF-β pathway crosstalk in endothelial cells.
Tian H; Mythreye K; Golzio C; Katsanis N; Blobe GC
EMBO J; 2012 Oct; 31(19):3885-900. PubMed ID: 22940691
[TBL] [Abstract][Full Text] [Related]
8. Insulin-Like Growth Factor-1 Contributes to Mucosal Repair by β-Arrestin2-Mediated Extracellular Signal-Related Kinase Signaling in Experimental Colitis.
Chen T; Zheng F; Tao J; Tan S; Zeng L; Peng X; Wu B
Am J Pathol; 2015 Sep; 185(9):2441-53. PubMed ID: 26362717
[TBL] [Abstract][Full Text] [Related]
9. HSP27 phosphorylation modulates TRAIL-induced activation of Src-Akt/ERK signaling through interaction with β-arrestin2.
Qi S; Xin Y; Qi Z; Xu Y; Diao Y; Lan L; Luo L; Yin Z
Cell Signal; 2014 Mar; 26(3):594-602. PubMed ID: 24308965
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
[TBL] [Abstract][Full Text] [Related]
11. Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1.
Lux A; Attisano L; Marchuk DA
J Biol Chem; 1999 Apr; 274(15):9984-92. PubMed ID: 10187774
[TBL] [Abstract][Full Text] [Related]
12. Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex.
Blanco FJ; Santibanez JF; Guerrero-Esteo M; Langa C; Vary CP; Bernabeu C
J Cell Physiol; 2005 Aug; 204(2):574-84. PubMed ID: 15702480
[TBL] [Abstract][Full Text] [Related]
13. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.
Lebrin F; Goumans MJ; Jonker L; Carvalho RL; Valdimarsdottir G; Thorikay M; Mummery C; Arthur HM; ten Dijke P
EMBO J; 2004 Oct; 23(20):4018-28. PubMed ID: 15385967
[TBL] [Abstract][Full Text] [Related]
14. Beta-arrestin2 enhances beta2-adrenergic receptor-mediated nuclear translocation of ERK.
Kobayashi H; Narita Y; Nishida M; Kurose H
Cell Signal; 2005 Oct; 17(10):1248-53. PubMed ID: 16038799
[TBL] [Abstract][Full Text] [Related]
15. Beta-arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration.
Kim J; Zhang L; Peppel K; Wu JH; Zidar DA; Brian L; DeWire SM; Exum ST; Lefkowitz RJ; Freedman NJ
Circ Res; 2008 Jul; 103(1):70-9. PubMed ID: 18519945
[TBL] [Abstract][Full Text] [Related]
16. Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes.
Shenoy SK; Lefkowitz RJ
J Biol Chem; 2005 Apr; 280(15):15315-24. PubMed ID: 15699045
[TBL] [Abstract][Full Text] [Related]
17. Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation.
Sun Y; Cheng Z; Ma L; Pei G
J Biol Chem; 2002 Dec; 277(51):49212-9. PubMed ID: 12370187
[TBL] [Abstract][Full Text] [Related]
18. Endoglin regulates the activation and quiescence of endothelium by participating in canonical and non-canonical TGF-β signaling pathways.
Park S; Dimaio TA; Liu W; Wang S; Sorenson CM; Sheibani N
J Cell Sci; 2013 Mar; 126(Pt 6):1392-405. PubMed ID: 23418351
[TBL] [Abstract][Full Text] [Related]
19. Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway.
Pece-Barbara N; Vera S; Kathirkamathamby K; Liebner S; Di Guglielmo GM; Dejana E; Wrana JL; Letarte M
J Biol Chem; 2005 Jul; 280(30):27800-8. PubMed ID: 15923183
[TBL] [Abstract][Full Text] [Related]
20. Regulation of TGF-β receptor hetero-oligomerization and signaling by endoglin.
Pomeraniec L; Hector-Greene M; Ehrlich M; Blobe GC; Henis YI
Mol Biol Cell; 2015 Sep; 26(17):3117-27. PubMed ID: 26157163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
